GO-PEN® receives FDA 510(k) clearance for innovative user-filled insulin pen
Danish medical device company GO-Pen ApS receives FDA clearance for its cost-effective user-filled insulin pen, addressing the need for affordable insulin delivery solutions. This technology aims to improve diabetes care for over 20 million insulin users still dependent on vials and syringes globally, with market entry preparations now underway in the United States and beyond.
Why does GO-Pen exist?
GO-Pen’s CEO and co-founder Ole Kjerkegaard Nielsen, featured in Dutch TV-programme De Barometer, explains why he started the company and how GO-Pen will improve diabetes care for millions of people.